Mucoactive therapy in the practice of an otorhinolaryngologist
- Авторлар: Sinkov E.V.1, Svistushkin V.M1, Shadyev T.K.1, Stozhkova I.V1
-
Мекемелер:
- Sechenov First Moscow State Medical University (Sechenov University)
- Шығарылым: Том 27, № 5 (2020)
- Беттер: 114-116
- Бөлім: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312655
- DOI: https://doi.org/10.18565/pharmateca.2020.5.114-116
- ID: 312655
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
Авторлар туралы
Eduard Sinkov
Sechenov First Moscow State Medical University (Sechenov University)Department of Ear, Nose and Throat Diseases, N.V. Sklifosovsky Institute of Clinical Medicine; Cand. Sci. (Med.), Associate Professor at the Department of Ear, Nose and Throat Diseases 6, build. 1, Bolshaya Pirogovskaya str., Moscow 119435, Russian Federation
V. Svistushkin
Sechenov First Moscow State Medical University (Sechenov University)Department of Ear, Nose and Throat Diseases, N.V. Sklifosovsky Institute of Clinical Medicine Moscow, Russia
T. Shadyev
Sechenov First Moscow State Medical University (Sechenov University)Department of Ear, Nose and Throat Diseases, N.V. Sklifosovsky Institute of Clinical Medicine Moscow, Russia
I. Stozhkova
Sechenov First Moscow State Medical University (Sechenov University)Department of Ear, Nose and Throat Diseases, N.V. Sklifosovsky Institute of Clinical Medicine Moscow, Russia
Әдебиет тізімі
- Пискунов Г.З. Физиология и патофизиология носа и околоносовых пазух. Российская ринология. 2017;25(3):51. doi: 10.17116/rosrino201725351-57.
- Карпищенко С.А., Алексеенко С.И., Колесникова О.М. Мукоактивная терапия. Перспективы применения в оториноларингологии. Consilium Medicum. 2017;19(3):44-9.
- Rubin B.K. The pharmacologic approach to airway clearance: mucoactive agents. Respir Care. 2002;47(7):818-22. doi: 10.1016/j.prrv.2006.04.198.
- Гаращенко Т.И. Мукоактивные препараты в лечении заболеваний околоносовых пазух. РМЖ. 2001;19:806.
- Клячкина И.Л. Новые возможности лечения кашля. Вестник оториноларингологии. 2015;80(5):85-90. doi: 10.17116/otorino201580585-90.
- Чучалин А.Г. Рациональная фармакотерапия заболеваний органов дыхания. М., 2013. 872 c.
- Mata M., et al. Respiratory Syncytial Virus Inhibits Ciliagenesis in Differentiated Normal Human Bronchial Epithelial Cells: Effectiveness of N-Acetylcysteine. PLoS. One. ed. H.W Chu. Publ. Libr. Sci. 2012;7(10):e48037. doi: 10.1371/journal.pone.0048037.
- Li X., et al. Ambroxol hydrochloride combined with fluconazole reverses the resistance of Candida albicans to fluconazole. Front. Cell Infect Microbiol. 2017;7(APR):1-8. doi: 10.3389/fcimb.2017.00124.
- Ueda N., et al. Inhibitory effects of TNF-alpha and IFN-gamma on ciliary beat frequency of cultured human sinus epithelial cells and its modulation by ambroxol hydrochloride. Pract Otol Soc Pract Otolaryngol. 2000;93(2):167-73.
- Malerba M., Ragnoli B. Ambroxol in the 21st century: Pharmacological and clinical update. Expert Opin Drug Metab Toxicol. 2008;4(8):1119-29. doi: 10.1517/17425255.4.8.1119.
- Scaglione F., Petrini O. Mucoactive Agents in the Therapy of Upper Respiratory Airways Infections: Fair to Describe Them Just as Mucoactive? Clin. Med. Insights Ear, Nose Throat. 2019;12:1-9. doi: 10.1177/1179550618821930.